Pavaki Capital Management LLC 13F 持仓 · 2026年Q2
Pavaki Capital Management 在 2026年Q2（报告期截至 2026-06-30）的 SEC 13F 申报中报告了 132 只证券，申报市值合计 2.87 亿美元。前几大持仓：CVNA（14.23%）、QQQ（7.06%）、TSLA（6.38%）。本季前 25 大持仓中：新建仓 3 只、增持 9 只。
| 排名 | 代码 | 公司 | 市值 | 占组合 | 股数 | 变动 |
|---|---|---|---|---|---|---|
| 1 | CVNA | CARVANA CO | $40.8M | 14.23% | 620,000 | 增持 |
| 2 | QQQ | INVESCO QQQ TR | $20.3M | 7.06% | 27,500 | 增持 |
| 3 | TSLA | TESLA MTRS INC | $18.3M | 6.38% | 43,500 | 持平 |
| 4 | CVX | CHEVRON CORP NEW | $16.1M | 5.61% | 97,000 | 增持 |
| 5 | MIST | MILESTONE PHARMACEUTICALS IN | $12.2M | 4.24% | 9.1M | 增持 |
| 6 | INTU | INTUIT | $10.1M | 3.51% | 38,600 | 新建仓 |
| 7 | QCOM | QUALCOMM INC | $9.1M | 3.16% | 49,000 | 新建仓 |
| 8 | B | BARRICK MNG CORP | $8.1M | 2.84% | 221,500 | 持平 |
| 9 | TXT | TEXTRON INC | $7.7M | 2.70% | 84,300 | 增持 |
| 10 | PLTR | PALANTIR TECHNOLOGIES INC | $6.9M | 2.42% | 59,500 | 持平 |
| 11 | REGN | REGENERON PHARMACEUTICALS | $6.2M | 2.15% | 9,900 | 增持 |
| 12 | NVDA | NVIDIA CORPORATION | $5.2M | 1.81% | 26,000 | 增持 |
| 13 | ARQT | ARCUTIS BIOTHERAPEUTICS INC | $4.9M | 1.71% | 187,000 | 持平 |
| 14 | SPRY | SILVERBACK THERAPEUTICS INC | $4.6M | 1.62% | 579,600 | 增持 |
| 15 | MU | MICRON TECHNOLOGY INC | $4.6M | 1.61% | 4,000 | 新建仓 |
| 16 | BTG | B2GOLD CORP | $4.4M | 1.54% | 1.2M | 持平 |
| 17 | LGND | LIGAND PHARMACEUTICALS INC | $3.5M | 1.22% | 11,100 | 持平 |
| 18 | APP | APPLOVIN CORP COM | $3.2M | 1.11% | 6,200 | 持平 |
| 19 | CGAU | CENTERRA GOLD INC | $3.1M | 1.09% | 197,000 | 持平 |
| 20 | NEM | NEWMONT GOLDCORP CORPORATION | $3.0M | 1.06% | 32,500 | 持平 |
| 21 | SLB | SCHLUMBERGER LTD | $2.8M | 0.99% | 61,000 | 增持 |
| 22 | HRMY | HARMONY BIOSCIENCES HLDGS IN | $2.7M | 0.93% | 73,000 | 持平 |
| 23 | AVGO | BROADCOM INC | $2.6M | 0.92% | 7,000 | 持平 |
| 24 | RPRX | ROYALTY PHARMA PLC SHS | $2.5M | 0.86% | 44,000 | 持平 |
| 25 | AMD | ADVANCED MICRO DEVICES INC | $2.3M | 0.81% | 4,000 | 持平 |
来源：SEC 13F 申报文件 · 截至 2026-06-30
本期 13F-HR 中的全部持仓，以及相对上季度的变化。
13F 持仓，最新季度
来源SEC EDGAR13F-HR